Repositorio Dspace

Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine

Mostrar el registro sencillo del ítem

dc.contributor.author Videla Richardson, Guillermo Agustín
dc.contributor.author Furmento, Verónica Alejandra
dc.contributor.author García, Carolina Paola
dc.contributor.author Morris-Hanon, Olivia
dc.contributor.author Sevlever, Gustavo Emilio
dc.contributor.author Romorini, Leonardo
dc.contributor.author Scassa, María Élida
dc.date.accessioned 2019-10-23T18:04:58Z
dc.date.available 2019-10-23T18:04:58Z
dc.date.issued 2019-08-28
dc.identifier.citation Videla-Richardson GA, Furmento VA, Garcia CP, et al. Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine. BMC Molecular and Cell Biology. 2019;20(1):40. doi:10.1186/s12860-019-0222-3 en_US
dc.identifier.uri https://doi.org/10.1186/s12860-019-0222-3
dc.identifier.uri https://repositorio.fleni.org.ar/handle/123456789/68
dc.description.abstract BACKGROUND: The essentially unlimited expansion potential and the pluripotency of human embryonic stem cells (hESCs) make them attractive for cell-based therapeutic purposes. Although hESCs can indefinitely proliferate in culture, unlike transformed cancer cells, they are endowed with a cell-intrinsic property termed mitochondrial priming that renders them highly sensitive to apoptotic stimuli. Thus, all attempts to broaden the insights into hESCs apoptosis may be helpful for establishing pro-survival strategies valuable for its in vitro culture and further use in clinical applications. Cyclin-dependent kinases (CDKs), a family of serine/threonine protein kinases originally identified as regulators of the eukaryotic cell cycle, can also regulate transcription and differentiation. Moreover, there are compelling data suggesting that its activities are involved in certain apoptotic programs in different cell types. Currently, it is not completely determined whether CDKs regulate apoptotic processes in rapidly proliferating and apoptosis-prone hESCs. In this study, to elucidate the effect of CDKs inhibition in hESCs we used Roscovitine (ROSC), a purine analogue that selectively inhibits the activities of these kinases. RESULTS: Inhibition of CDKs by ROSC triggers programmed cell death in hESCs but not in proliferating somatic cells (human fibroblasts). The apoptotic process encompasses caspase-9 and -3 activation followed by PARP cleavage. ROSC treatment also leads to p53 stabilization, which coincides with site-specific phosphorylation at serine 46 and decreased levels of Mdm2. Additionally, we observed a transcriptional induction of p53AIP1, a repression of pro-survival factor Mcl-1 and an up-regulation of pro-apoptotic BH3-only proteins NOXA and PUMA. Importantly, we found that the role of CDK2 inhibition appears to be at best accessory as an active CDK2 is not required to ensure hESCs survival. CONCLUSION: Our experimental data reveal that hESCs, contrary to fibroblasts, exhibit a pronounced sensitivity to ROSC. en_US
dc.language.iso eng en_US
dc.publisher Biomed Central en_US
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri https://creativecommons.org/licenses/by/2.5/ar/
dc.subject Apoptosis en_US
dc.subject Cyclin-Dependent Kinases en_US
dc.subject Quinasas Ciclina-Dependientes en_US
dc.subject Human Embryonic Stem Cells en_US
dc.subject Roscovitine en_US
dc.subject Roscovitina en_US
dc.title Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine en_US
dc.type info:eu-repo/semantics/publishedVersion
dc.type info:eu-repo/semantics/article en_US
dc.description.fil Fil: Videla Richardson, Guillermo A. Fleni. Laboratorio de Investigación Aplicada a las Neurociencias; Argentina.
dc.description.fil Fil: Furmento, Verónica A. Fleni. Laboratorio de Investigación Aplicada a las Neurociencias; Argentina.
dc.description.fil Fil: García, Carolina Paola. Fleni. Laboratorio de Investigación Aplicada a las Neurociencias; Argentina.
dc.description.fil Fil: Morris-Hanon, Olivia. Fleni. Laboratorio de Investigación Aplicada a las Neurociencias; Argentina.
dc.description.fil Fil: Sevlever, Gustavo Emilio. Fleni. Laboratorio de Investigación Aplicada a las Neurociencias; Argentina.
dc.description.fil Fil: Romorini, Leonardo. Fleni. Laboratorio de Investigación Aplicada a las Neurociencias; Argentina.
dc.description.fil Fil: Romorini, Leonardo. Fleni. Laboratorio de Investigación Aplicada a las Neurociencias; Argentina.
dc.description.fil Fil: Scassa, María E. Fleni. Laboratorio de Investigación Aplicada a las Neurociencias; Argentina.
dc.relation.ispartofVOLUME 20
dc.relation.ispartofCOUNTRY Reino Unido
dc.relation.ispartofCITY Londres
dc.relation.ispartofISSN 2661-8850
dc.type.snrd info:ar-repo/semantics/artículo es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/openAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/openAccess

Buscar en DSpace


Listar

Mi cuenta

Estadísticas